EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Locoregional Treatment Options for Locally Advanced Intrahepatic Cholangiocarcinoma

Alex B Blair, Wilson M Alobuia, Manisha Palta, Steven S Raman, Matthew H Levine, Al B Benson, Michael I D'Angelica, Jordan M Cloyd

Journal of the National Comprehensive Cancer Network · 2025

DOI: 10.6004/jnccn.2025.7085 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of the National Comprehensive Cancer Network, 2025. Verfasst von Alex B Blair und 7 weiteren Autor:innen. Beteiligte Einrichtung: 1Division of Surgical Oncology, Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH. Hauptthemen laut MEDLINE: Cholangiocarcinoma, Bile Duct Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 99 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Intrahepatic cholangiocarcinoma (ICC) is an aggressive primary liver malignancy. Although surgical resection remains the standard of care, most patients present with either metastatic or locally advanced, unresectable disease. Although effective systemic therapy is paramount in these situations, locoregional tumor control frequently delays liver-related complications and mortality. To address this challenge, a variety of liver-directed therapies have emerged, including transarterial chemoembolization, transarterial radioembolization with yttrium-90, hepatic arterial infusion chemotherapy, external-beam radiation therapy and in select cases, liver transplantation. These modalities have shown promise in prolonging survival, enhancing local control, and in some instances, downstaging tumors to resectability. This review examines recent advancements in locoregional treatment options for unresectable ICC, highlights their use and associated outcomes, and explores general guidelines for optimal patient selection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CholangiocarcinomaBile Duct NeoplasmsBile Ducts, IntrahepaticChemoembolization, TherapeuticYttrium RadioisotopesAntineoplastic AgentsInfusions, Intra-ArterialHepatic ArteryLiver TransplantationTreatment OutcomeHumansPatient SelectionPractice Guidelines as TopicCombined Modality TherapyNeoplasm Staging

Substanzen

Yttrium-90Yttrium RadioisotopesAntineoplastic Agents

Autor:innen und Institutionen

  • 1Division of Surgical Oncology, Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH.
  • 2Department of Radiation Oncology, Duke University, Durham, NC.
  • 3Department of Radiological Sciences, David Geffen School of Medicine at The University of California Los Angeles, Los Angeles, CA.
  • 4Division of Transplantation, Department of Surgery, University of Pennsylvania, Philadelphia, PA.
  • 5Division of Hematology and Oncology, Department of Medicine, Northwestern University, Chicago, IL.
  • 6Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY.

Zitieren

APA

Blair, A. B., Alobuia, W. M., Palta, M., Raman, S. S., Levine, M. H., Benson, A. B., D'Angelica, M. I., & Cloyd, J. M. (2025). Locoregional Treatment Options for Locally Advanced Intrahepatic Cholangiocarcinoma. Journal of the National Comprehensive Cancer Network. https://doi.org/10.6004/jnccn.2025.7085

Vancouver

Blair AB, Alobuia WM, Palta M, Raman SS, Levine MH, Benson AB, et al. Locoregional Treatment Options for Locally Advanced Intrahepatic Cholangiocarcinoma. Journal of the National Comprehensive Cancer Network. 2025. doi:10.6004/jnccn.2025.7085

BibTeX
@article{Blair2025,
  author = {Blair, Alex B and Alobuia, Wilson M and Palta, Manisha and Raman, Steven S and Levine, Matthew H and Benson, Al B and D'Angelica, Michael I and Cloyd, Jordan M},
  title = {Locoregional Treatment Options for Locally Advanced Intrahepatic Cholangiocarcinoma},
  journal = {Journal of the National Comprehensive Cancer Network},
  year = {2025},
  doi = {10.6004/jnccn.2025.7085}
}
Kostenlos starten →